内分泌

内分泌関連疾患の症例におけるInBody使用の論文
※各論文の要約資料(日本語)が必要な場合、サポート情報の「臨床のご相談」よりご依頼ください。

2型糖尿病患者において、ダパグリフロジンは筋肉量に影響を及ぼさず体脂肪量を減少させる
2018 / InBody770 / Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan
Seigo Sugiyama, Hideaki Jinnouchi, Noboru Kurinami, Kunio Hieshima, Akira Yoshida, Katsunori Jinnouchi, Hiroyuki Nishimura, Tomoko Suzuki, Fumio Miyamoto, Keizo Kajiwara, and Tomio Jinnouchi. Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes. J Atheroscler Thromb, 25: 467-476

バセドウ病治療中の体成分及び基礎代謝量の変化
2018 / InBody720 / Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
Min Joo Kim, Sun Wook Cho, Sumin Choi, Dal Lae Ju, Do Joon Park, and Young Joo Park. Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves’ Disease. International Journal of Endocrinology, Article ID9863050: 8

2型糖尿病患者の食後糖代謝及び腸ペプチドにおけるイプラグリフロジンの効果:パイロット試験
2018 / InBody720 / Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
Hiroaki Ueno, Hiroko Nakazato, Emi Ebihara, Kenji Noma, Takahisa Kawano, Kazuhiro Nagamine, Hideyuki Sakoda, Masamitsu Nakazato. Effects of Ipragliflozin on Postprandial Glucose Metabolism and Gut Peptides in Type 2 Diabetes: A Pilot Study. Diabetes Ther, 9: 403–411

血糖管理が不適切な2型糖尿病患者における、単剤治療または他の経口糖尿病治療薬と併用したイプラグリフロジンの効果: 患者の特徴に基づいた下位群分析
2018 / InBody3.2 / Department of Internal Medicine, Naka Kinen Clinic, Naka, Ibaraki, Japan
Takeshi Osonoi, Shinya Nakamoto, Miyoko Saito, Atsuko Tamasawa, Hidenori Ishida, Yusuke Osonoi. Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics. J Diabetes Investig 2018, 9: 341–353

2型糖尿病患者の体成分及び血糖管理におけるトホグリフロジンの効果
2018 / InBody770 / Department of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Kurashiki, Japan
Shinji Kamei, Masahiro Iwamoto, Miyuki Kameyama, Masashi Shimoda, Tomoe Kinoshita, Atsushi Obata, Tomohiko Kimura, Hidenori Hirukawa, Fuminori Tatsumi, Kenji Kohara, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, and Hideaki Kaneto. Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus. Journal of Diabetes Research, Article ID6470137: 6

糖尿病を区別するためのグルコース非依存の部位別位相角
2018 / InBody S10 / KM Fundamental Research Division, Korea Institute of Oriental Medicine (KIOM), Daejeon, Korea
Min-Ho Jun, Soochan Kim, Boncho Ku, JungHee Cho, Kahye Kim, Ho-Ryong Yoo & Jaeuk U. Kim. Glucose-independent segmental phase angles from multi-frequency bioimpedance analysis to discriminate diabetes mellitus. Scientific Reports, 8: 648

2型糖尿病と高血圧の患者において、少量のサイアザイド系利尿薬をSGLT2阻害薬に変更することは、血圧に影響せずに様々な代謝機能を改善できる
2018 / InBody770 / Division of Diabetes, Endocrinology and Metabolism, Kawasaki Medical School, Kurashiki, Okayama, Japan
Tomohiko Kimura, Junpei Sanada, Masashi Shimoda, Hidenori Hirukawa, Yoshiro Fushimi, Momoyo Nishioka, Tomoe Kinoshita, Seizo Okauchi, Atsushi Obata, Kenji Kohara, Fuminori Tatsumi, Shinji Kamei, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto. Switching from low-dose thiazide diuretics to sodium–glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension. J Diabetes Investig, 9(4): 875-881

韓国の非糖尿病若年成人における、年齢・性別による体成分の変化
2017 / InBody3.0 / Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul
Seul-Ki Kim, Yu-Hyun Kwon, Jung Hwan Cho, Da Young Lee, Se Eun Park, Hyung-Geun Oh, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee. Changes in Body Composition According to Age and Sex among Young Non-Diabetic Korean Adults: The Kangbuk Samsung Health Study. Endocrinol Metab 2017, 32: 442-450

急激な体重減量と緩慢な体重減量: どちらが体成分及び代謝のリスク因子により効果的か?
2017 / InBody230 / Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Damoon Ashtary-Larky, Matin Ghanavati, Nasrin Lamuchi-Deli, Seyedeh Arefeh Payami, Sara Alavi-Rad, Mehdi Boustaninejad, Reza Afrisham, Amir Abbasnezhad, and Meysam Alipour. RapidWeight Loss vs. SlowWeight Loss: Which is More Effective on Body Composition and Metabolic Risk Factors?. Int J Endocrinol Metab, 15(3): e13249

糖尿性腎疾患患者においてSGLT2阻害薬(ダパグリフロジン)は細胞外液量増加を改善させる
2017 / InBody S10 / Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan
Takahiro Masuda, Ken Ohara, Takuya Murakami, Toshimi Imai, Saki Nakagawa, Mari Okada, Atsushi Miki, Akihiro Myoga, Akira Onishi, Chuji Sekiguchi, Yasuharu Miyazawa, Tetsu Akimoto,Osamu Saito, Shigeaki Muto, and Daisuke Nagata. Sodium-Glucose cotransporter 2 Inhibition with Dapagliflozin Ameliorates Extracellular Volume Expansion in Diabetic Kidney Disease Patients. POJ Diabetes Obes, 1(1): 1-8

植物性タンパク質を中心としたタンパク質摂取は、2型糖尿病の高齢者において骨格筋量の多さと関連している
2017 / InBody720 / Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan
Akane Miki, Yoshitaka Hashimoto, Shinobu Matsumoto, Emi Ushigome, Takuya Fukuda, Takafumi Sennmaru, Muhei Tanaka, Masahiro Yamazaki, and Michiaki Fukui. Protein Intake, Especially Vegetable Protein Intake, Is Associated with Higher Skeletal Muscle Mass in Elderly Patients with Type 2 Diabetes. Journal of Diabetes Research, Article ID7985728: 7 

相対的筋肉量と2型糖尿病の発症リスク: コホート研究
2017 / InBody720 / Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
Sungwoo Hong, Yoosoo Chang, Hyun-Suk Jung, Kyung Eun Yun, Hocheol Shin, Seungho Ryu. Relative muscle mass and the risk of incident type 2 diabetes: A cohort study. PLOS ONE | https://doi.org/10.1371/journal.pone.0188650

骨と体成分における抗甲状腺薬治療の影響: ヨウ素治療と抗甲状腺薬治療の比較
2017 / InBody720 / Department of Endocrinology, Army Hospital(R&R), New Delhi, India
Shekhar Kansara, Narendra Kotwal, K. V. S. Hari Kumar, Yashpal Singh, Vimal Upreti, Amit Nachankar. Effect of Antithyroid Therapies on Bone and Body Composition: A Prospective, Randomized, Clinical Study Comparing Antithyroid Drugs with Radioiodine Therapy. Indian J Endocr Metab 2017, 21: 531-534

2型糖尿病患者においてGLP-1受容体刺激薬(リラグルチド)にSGLT2阻害薬(ルセオグリフロジン)を加えることは血糖コントロールを改善させ、体重・体脂肪量を減少させる
2017 / InBody S10 / Kansai Electric Power Hospital, Osaka, Japan
Yutaka Seino, Daisuke Yabe, Takashi Sasaki, Atsushi Fukatsu, Hisae Imazeki, Hidekazu Ochiai, Soichi Sakai. Sodium-glucose cotransporter-2 inhibitor luseogliflozin added to glucagon-like peptide 1 receptor agonist liraglutide improves glycemic control with bodyweight and fat mass reductions in Japanese patients with type 2 diabetes: A 52-week, open-label, single-arm study. J Diabetes Investig, 9(2): 332-340

1型糖尿病患者において終末糖化産物(Advanced Glycation End-products; AGEs)は筋肉弱化のリスク要因である
2017 / InBody430 / Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan
Hiroyasu Mori, Akio Kuroda, Michiko Araki, Reiko Suzuki, Satoshi Taniguchi, Motoyuki Tamaki, Yuko Akehi, Munehide Matsuhisa. Advanced glycation end-products are a risk for muscle weakness in Japanese patients with type 1 diabetes. J Diabetes Investig 2017, 8: 377–382

既存療法を受けている2型糖尿病患者におけるイプラグリフロジンの効果及び安全性:イプラグリフロジン治療中の運動習慣の重要性に関する臨床的意味
2017 / InBody720 / Kato Clinic of Internal Medicine, Tokyo, Japan
Mitsutoshi Kato, Kumiko Sakai, Kyoko Saito, Kensuke Tsutsui, Shigeo Yamashita, Noriko Kato. Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes receiving conventional therapy: clinical implication of the importance of exercise habits during treatment with ipragliflozin. Diabetol Int, 8(3): 275-285

SGLT2阻害薬(イプラグリフロジン)の2型糖尿病患者における脂肪肝指数の改善: 血糖降下効果との関係
2017 / InBody720 / Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Takahiro Takase, Akinobu Nakamura, Hideaki Miyoshi, Chiho Yamamoto and Tatsuya Atsumi. Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects. Endocr J, 64(3): 363-367

治療を受けていない2型糖尿病患者における高インスリン正常血糖クランプ法を使用したインスリン感受性と筋肉/脂肪の相関
2016 / InBody770 / Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan
Noboru Kurinami, Seigo Sugiyamaa, Akira Yoshida, Kunio Hieshima, Fumio Miyamoto, Keizo Kajiwara, Tomio Jinnouchi, Hideaki Jinnouchi. Correlation of body muscle/fat ratio with insulin sensitivity using hyperinsulinemic-euglycemic clamp in treatment-naı¨ve type 2 diabetes mellitus. diabetes research and clinical practice 120: 65–72

食事療法を受けている2型糖尿病患者におけるイプラグリフロジンは効果的に内臓脂肪を減少させる
2016 / InBody720 / Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Chiho Yamamoto, Hideaki Miyoshi, Kota Ono, Hajime Sugawara, Reina Kameda, Mei Ichiyama, Kohei Yamamoto, Hiroshi Nomoto, Akinobu Nakamura and Tatsuya Atsumi. Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy. Endocr J, 63(6): 589-596

2型糖尿病男性における脂肪肝と骨格筋指数の関係
2016 / InBody720 / Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan
Yoshitaka Hashimoto, Takafumi Osaka, Takuya Fukuda, Muhei Tanaka, Masahiro Yamazaki and Michiaki Fukui. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes. Endocr J, 63(10): 877-884

2型糖尿病患者における空腹時血糖値・HbA1c・トリグリセリドの変化は、体成分の変化と関連している
2016 / InBody720 / Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Anca HANCU, Gabriela RADULIAN. Changes in Fasting Plasma Glucose, HbA1c and Triglycerides Are Related to Changes in Body Composition in Patients with Type 2 Diabetes. MAEDICA – a Journal of Clinical Medicine 2016, 11(5): 32-37

2型糖尿病肥満患者の部位別脂肪分布・糖化ヘモグロビン濃度・大動脈脈波速度における短期エクセナチド治療の効果
2016 / InBody720 / Division of Endocrinology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea
Ju-Young Hong, Keun-Young Park, Byung-Joon Kim, Won-Min Hwang, Dong-Ho Kim, Dong-Mee Lim. Effects of Short-Term Exenatide Treatment on Regional Fat Distribution, Glycated Hemoglobin Levels, and Aortic Pulse Wave Velocity of Obese Type 2 Diabetes Mellitus Patients. Endocrinol Metab 2016, 31: 80-85

韓国の社会生活・健康及び高齢化プロジェクトにおける高齢者の四肢骨格筋量とインスリン抵抗の関係性
2015 / InBody370 / Department of Public Health, Yonsei University Graduate School, Seoul, Korea
Seung Won Lee, Yoosik Youm, Won Joon Lee, Wungrak Choi, Sang Hui Chu, Yeong-Ran Park, Hyeon Chang Kim. Appendicular Skeletal Muscle Mass and Insulin Resistance in an Elderly Korean Population: The Korean Social Life, Health and Aging Project-Health Examination Cohort. Diabetes Metab J 2015, 39: 37-45

イプラグリフロジン(SGLT2阻害薬)の臨床的効果とBIA法による体成分変化の検討
2014 / InBody770 / Takagi Internal Medical Clinic, Kyoto, Japan
高木秀一、高木美幸、樹山敦子、中村直登. イプラグリフロジン(SGLT2阻害薬)の臨床的効果とBIA法による体成分変化の検討. Progress in Medicine, 34(12): 2229-2235

血清クレアチニン濃度の変化は2型糖尿病のリスクと関連がある
2013 / InBody720 / Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea
Jun Sung Moon, Ji Eun Lee, Ji Sung Yoon. Variation in Serum Creatinine Level Is Correlated to Risk of Type 2 Diabetes. Endocrinol Metab 2013, 28: 207-213

非アルコール性脂肪肝疾患の発病における骨格筋の役割
2013 / InBody720 / Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea
Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee. The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease. Diabetes Metab J 2013, 37: 278-285

腹部脂肪と無関係の四肢の皮下脂肪は、日本人の2型糖尿病患者のインスリン抵抗性及び心血管系の危険性を増進しない
2013 / InBody720 / Division of Endocrinology and Metabolism, Kurume University School of Medicine, Kurume, Japan
Yuji Tajiri , Koji Yonemoto, Kentaro Yamada. Subcutaneous fat of extremities independent of abdominal fat does not promote insulin resistance and cardiovascular risk in Japanese type 2 diabetic patients. Diabetol Int 2013, 4: 45–51

2型糖尿病患者の内臓脂肪量と血液HbA1cの季節別変化
2012 / InBody720 / Division of Dietary Service, Mie University School Hospital, Tsu, Japan
Motoh Iwasa, Tomoe Nakatani, Yutaka Yano, Rumi Mifuji-Moroka, Nagisa Hara, Miho Akamatsu, Masumi Ishidome, Yoshiyuki Takei. Seasonal variation in visceral fat and blood HbA1c in people with type 2 diabetes. diabetes research and clinical practice 96: e53–e54

脂質降下薬を服用中の高脂血症患者における卵摂取の影響
2012 / InBody720 / Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Theerawut Klangjareonchai, Supanee Putadechakum, Piyamitr Sritara, Chulaporn Roongpisuthipong. The Effect of Egg Consumption in Hyperlipidemic Subjects during Treatment with Lipid-Lowering Drugs. Journal of Lipids 2012; Article ID672720: 4

内臓脂肪量は、慢性C型肝炎患者における、2型糖尿病に対する予測指標となる
2011 / InBody720 / Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Japan
Motoh Iwasa, Rumi Mifuji-Moroka, Nagisa Hara, Masumi Ishidome, Kazuko Iwata, Ryosuke Sugimoto, Hideaki Tanaka, Naoki Fujita, Yoshinao Kobayashi, Yoshiyuki Takei. Visceral fat volume predicts new-onset type 2 diabetes in patients with chronic hepatitis C. Diabetes Research and Clinical Practice 2011, 94: 468–470

日本人の2型糖尿病患者における骨格筋量(下肢筋肉量)の減少と、インスリン抵抗性及び動脈硬化の危険因子
2010 / InBody720 / Endocrinology and Metabolism Division, Kurume University School of Medicine, Kurume, Japan
Yuji Tajiri, Tomoko Kato, Hitomi Nakayama, Kentaro Yamada. Reduction of Skeletal Muscle, Especially in Lower Limbs in Japanese Type 2 Diabetic Patients with Insulin Resistance and Cardiovascular Risk Factors. Metabolic Syndrome and Related Disorders 2010, 8(2): 137-142

高齢の2型糖尿病患者における激しい骨格筋量の減少
2009 / DEXA, CT / Department of Internal Medicine, CHA University, Sungnam, Korea
Seok won park, Bret H. Goodpaster, Jung Sun Lee, Lewis H. Kuller, Robert Boudreau, Nathalie De Rekeneire, Tamara B. Harris, Stephen Kritchevsky, Frances A. Tylavsky, Michael Nevitt, Yong-Wook Cho, Anne B. Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes. Diabetes Care 32: 1993–1997 (Not Using InBody)

2型糖尿病患者における、除脂肪体重と血清クレアチニン濃度を用いる、推定クレアチニンクリアランスの新しい方程式の導出
2009 / InBody2.0 / Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul, Korea
Eunkyung Lee, Youngmin Cho, Jintaek Kim, Bokyung Koo, Hwayoung Cho, Yunhyi Ku, Kyongsoo Park, Hakchul Jang, Seongyeon Kim, Hongkyu Lee. Derivation of a new equation for estimating creatinine clearance by using fat-free mass and serum creatinine concentration in Korean patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2009, 83: 44–49

妊娠性糖尿病の病歴を持つ女性における腹部脂肪とインシュリン感受性
2007 / InBody3.0 / Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
Soo Lim, Sung Hee Choi, Young Joo Park, Kyong Soo Park, Hong Kyu Lee, Hak C. Jang, Nam H. Cho, Boyd E. Metzger. Visceral Fatness and Insulin Sensitivity in Women With a Previous History of Gestational Diabetes Mellitus. Diabetes Care, 30(2)